Bocchi Federica, Schietzel Simeon, Huynh-Do Uyen, Vogt Bruno, Sidler Daniel
Department of Nephrology and Hypertension, Inselspital, Bern University Hospital, Bern, Switzerland.
Front Nephrol. 2024 Jul 16;4:1385447. doi: 10.3389/fneph.2024.1385447. eCollection 2024.
In kidney transplant (KT) patients, magnesium (Mg) deficiency is widespread. It is often encountered early after KT, may persist longer, and is frequently promoted by calcineurin inhibitors (CNIs) and tubular leakage. Studies demonstrated an association between post-KT hypomagnesemia and allograft dysfunction. The concentration of the active form, the ionized Mg (iMg), is not measured clinically, and total Mg (tMg) and iMg correlations are conflicting. We assess the cross-sectional prevalence of hypomagnesemia in KT patients. The correlation of demographic and anthropometric parameters was also studied.
A prospective, single-center analysis of KT patients was conducted at the University Hospital of Bern, Switzerland (March 2023-August 2023). Blood samples were collected at least twice for the majority of patients. tMg has been quantified from a plasma sample at the Clinical Chemistry Department of the University Hospital of Bern. The PRIME ES analyzer (Nova Biomedical, USA) provided results for iMg. The following co-variables were considered: age, comorbidities, kidney disease, KT history, estimated glomerular filtration rate (eGFR), and treatment (including Mg supplementation and immunosuppression).
A total of 208 measurements in 104 patients were performed [once in 9/104 patients (8.7%), twice in 86/104 (82.7%), and three times in 9/104 (8.7%)]. Compared to that in healthy volunteers (51 measurements in 51 participants), mean iMg was significantly lower in KT patients {KT: 0.46 mmol/L [interquartile range (IQR): 0.40-0.50], volunteers: 0.57 mmol/L (IQR 0.54-0.61), p < 0.01}. Overall, iMg and tMg showed strong category agreement (r = 0.93, p < 0.01). In linear regression, low iMg correlated with CNI exposure. For 110/208 measurements (52.9%), a reduced iMg (cutoff: 0.42 mmol/L) was shown. In 58/208 (27.9%), both values were reduced, and 52/208 (25%) had isolated reduced iMg. In principal component analysis, patients with isolated low iMg clustered with patients with low iMg and tMg.
iMg and tMg were strongly correlated. A substantial proportion of patients show isolated low iMg. Currently, it is unclear if these patients suffer from Mg deficiency.
在肾移植(KT)患者中,镁(Mg)缺乏很普遍。它在KT术后早期经常出现,可能持续更长时间,并且经常由钙调神经磷酸酶抑制剂(CNIs)和肾小管渗漏导致。研究表明KT术后低镁血症与移植肾功能障碍之间存在关联。活性形式即离子化镁(iMg)的浓度未在临床中测量,并且总镁(tMg)与iMg的相关性存在争议。我们评估KT患者低镁血症的横断面患病率。还研究了人口统计学和人体测量学参数的相关性。
在瑞士伯尔尼大学医院(2023年3月至2023年8月)对KT患者进行了一项前瞻性单中心分析。大多数患者至少采集两次血样。tMg已在伯尔尼大学医院临床化学科从血浆样本中进行定量。PRIME ES分析仪(美国Nova Biomedical公司)提供iMg的检测结果。考虑了以下协变量:年龄、合并症、肾脏疾病、KT病史、估计肾小球滤过率(eGFR)以及治疗(包括镁补充和免疫抑制)。
对104例患者共进行了208次测量[9/104例患者(8.7%)测量1次,86/104例患者(82.7%)测量2次,9/104例患者(8.7%)测量3次]。与健康志愿者(51名参与者进行了51次测量)相比,KT患者的平均iMg显著更低{KT:0.46 mmol/L[四分位间距(IQR):0.40 - 0.50],志愿者:0.57 mmol/L(IQR 0.54 - 0.61),p < 0.01}。总体而言,iMg和tMg显示出很强的类别一致性(r = 0.93,p < 0.01)。在线性回归中,低iMg与接触CNIs相关。在208次测量中有110次(52.9%)显示iMg降低(临界值:0.42 mmol/L)。在208次测量中有58次(27.9%)两个值均降低,52次(25%)仅有iMg降低。在主成分分析中,仅有低iMg的患者与iMg和tMg均低的患者聚集在一起。
iMg和tMg密切相关。相当一部分患者仅有低iMg。目前尚不清楚这些患者是否存在镁缺乏。